Surveillance programmes for early detection of hepatocellular carcinoma

2Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Primary hepatocellular carcinoma (HCC) is the most commonly diagnosed primary malignancy of the liver. The number of new diagnosed cases of HCC seems to be on a rise worldwide. HCC is typically diagnosed in patients with underlying liver cirrhosis (> 90% cases) regardless of aetiology; over a five-year follow-up period HCC develops in 15-20% of patients with cirrhosis. Patients who are at a high risk of HCC development (i.e. individuals with liver cirrhosis, especially/ or chronically infected with HBV or HCV) should undergo regular screening for HCC; the current screening standard comprises liver ultrasonography and determination of α-fetoprotein (AFP) concentration in blood serum at ca. 6 months' intervals (now has been excluded from current diagnostic standards). Only such diagnostic methods are capable of detecting HCC early, and thus make it possible to treat the cancer effectively.

Cite

CITATION STYLE

APA

Simon, K., Serafinśka, S., & Pazgan-Simon, M. (2012). Surveillance programmes for early detection of hepatocellular carcinoma. Wspolczesna Onkologia. https://doi.org/10.5114/wo.2012.30057

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free